Status: Recruiting
An Unblinded, Single Arm, Pilot Observational Study to Test the Safety, Tolerability, Immunogenicity and the Biological Effects of TRB-001 Vaccination in Individuals Who Have Previously Undergone aSyn Immunotherapy
An unblinded, single arm, pilot observational study to test the safety, tolerability, immunogenicity and the biological effects of TRB-001 vaccination in individuals who have previously undergone aSyn immunotherapy
Participants needed: 6
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Tridem Bioscience FlexCoUpdated: Aug 20, 2026Locations: 1
Eligibility criteria
At least 18-years of age [+3]
Women of childbearing potential without use of contraception [+16]